Richard B. Hancock - 12 Jan 2023 Form 4 Insider Report for Avid Bioservices, Inc.

Role
Director
Signature
/s/ Stephen Hedberg, by Power of Attorney for Richard B. Hancock
Issuer symbol
N/A
Transactions as of
12 Jan 2023
Net transactions value
-$67,989
Form type
4
Filing time
13 Jan 2023, 19:03:33 UTC
Previous filing
16 Dec 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Sale $38,064 -2,379 -5.7% $16.00 39,134 12 Jan 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Options Exercise $7,407 +1,635 +4.2% $4.53 40,769 12 Jan 2023 Direct
transaction CDMO Common Stock, $0.001 par value Sale $26,160 -1,635 -4% $16.00 39,134 12 Jan 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Options Exercise $4,605 +986 +2.5% $4.67 40,120 12 Jan 2023 Direct
transaction CDMO Common Stock, $0.001 par value Sale $15,776 -986 -2.5% $16.00 39,134 12 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Stock Option (right to buy) Options Exercise $0 -1,635 -0.81% $0.000000 199,252 12 Jan 2023 Common Stock 1,635 $4.53 Direct F1, F2
transaction CDMO Stock Option (right to buy) Options Exercise $0 -986 -0.49% $0.000000 198,266 12 Jan 2023 Common Stock 986 $4.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2022.
F2 Stock option granted to the reporting person on May 7, 2019, vests in four (4) equal annual installments beginning May 7, 2020 and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting.
F3 Stock option granted to the reporting person on November 27, 2017 vested monthly over a three (3) year period and was fully-vested as of November 27, 2020.